IN COMBINATION
DARPin-Delivered Radiotherapy With Molecular Partners And Orano Med
In this episode of In Combination, CEO Patrick Amstutz of Molecular Partners and CEO Arnaud Lesegretain of Orano Med join host Tom von Gunden in a discussion of using DARPins (Designed Ankyrin Repeat Proteins) as vector delivery platforms for high-affinity bindin...
ABOUT IN COMBINATION
Covering a range of drug delivery process and design challenges, from formulation to device engineering, In Combination illuminates multiple "angles of vision" on a common topic based on the participants' differing types of roles or organizations.
MEET YOUR HOST
On each episode of In Combination, Drug Delivery Leader Chief Editor Tom von Gunden engages two or more industry professionals representing different roles and responsibilities in a discussion designed to illustrate their shared and/or divergent perspectives on the topic at hand.
Interested in joining Tom on an episode? Contact him today.
RECENT EPISODES
